Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program
Veracyte to Present at JMP Securities 2014 Healthcare Conference
Sanofi Reports Positive Phase 3 Results for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL)
Who's in front heading 'round the bend?
A roundup of investment news.
Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.
This screen finds stocks that would make it into Morningstar's Wide-Moat Focus strategy.